biotech · Uveal Melanoma · Choroidal Melanoma · AURA
Aura Biosciences
Aura Biosciences clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Boston, USA
- Founded
- 2009
- Employees
- 128
- Programs
- 6
- Drugs
- 3
- Patents
- 17
Aura Biosciences projects
6 ClinicalTrials.gov programs sponsored by Aura Biosciences.
Aura Biosciences has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AU-011-301
Aura Biosciences
Primary Indeterminate Lesions or Small Choroidal Melanoma
1 trial -
Bel-sar
Aura Biosciences
Choroidal Melanoma
1 trial -
AU-011
Aura Biosciences
Eye Cancer
1 trial -
AU-011
Aura Biosciences
Uveal Melanoma
1 trial -
Light-activated AU-011
Aura Biosciences
Uveal Melanoma
1 trial -
AU-011
Aura Biosciences
Non-muscle-invasive Bladder Cancer
1 trial
Frequently asked questions
How many clinical projects does Aura Biosciences have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.